Diagnos Laboratorium Utama Tbk. vs Buyung Poetra Sembada Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 24.4K 24h volume), while Buyung Poetra Sembada Tbk. trades at Rp53 (market cap 512.92B, 1.13M 24h volume). The key difference: Buyung Poetra Sembada Tbk. is the larger of the two by market cap, and Buyung Poetra Sembada Tbk. is more actively traded (1.13M versus 24.4K). Which is the better fit depends on your goals.
| DGNS | HOKI | |
|---|---|---|
Market Cap | 308B | 512.92B |
Volume | 24.4K | 1.13M |
Lot | 244 | 11.28K |
Turnover | 5.54M | 59.84M |
Average Price | 227.25 | 53.06 |
Value | 5.54M | 59.84M |
Indicative Equilibrium Price | 230 | 53 |
Indicative Equilibrium Volume | 110 | 164K |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Buyung Poetra Sembada Tbk (the “Company”) was established based on Notarial Deed No. 46 ofIchsan Tedjabuana, S.H., dated September 16, 2003.
Read more on HOKI →